Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,347 | 1,334 | 99.3% |
| Education | $148.89 | 4 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,983 | 203 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,283 | 133 | $0 (2024) |
| PFIZER INC. | $2,197 | 128 | $0 (2024) |
| ABBVIE INC. | $1,987 | 115 | $0 (2024) |
| Amgen Inc. | $1,310 | 66 | $0 (2024) |
| Lilly USA, LLC | $1,177 | 66 | $0 (2024) |
| GlaxoSmithKline, LLC. | $841.97 | 55 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $831.70 | 44 | $0 (2024) |
| Merck Sharp & Dohme LLC | $706.58 | 48 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $697.79 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,948 | 152 | AstraZeneca Pharmaceuticals LP ($523.90) |
| 2023 | $2,964 | 159 | ABBVIE INC. ($431.49) |
| 2022 | $3,089 | 168 | Novo Nordisk Inc ($493.76) |
| 2021 | $3,229 | 197 | AbbVie Inc. ($495.56) |
| 2020 | $2,336 | 147 | AstraZeneca Pharmaceuticals LP ($378.96) |
| 2019 | $2,728 | 170 | PFIZER INC. ($411.68) |
| 2018 | $2,543 | 169 | Novo Nordisk Inc ($415.70) |
| 2017 | $2,661 | 176 | PFIZER INC. ($258.85) |
All Payment Transactions
1,338 individual payment records from CMS Open Payments — Page 1 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.25 | General |
| 12/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: PAIN | ||||||
| 12/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: VACCINES | ||||||
| 12/02/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Vaccines | ||||||
| 11/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Obesity | ||||||
| 11/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.74 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: PAIN | ||||||
| 11/14/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/13/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: VACCINE | ||||||
| 10/31/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Neuroscience | ||||||
| 10/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Respiratory | ||||||
| 10/25/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Vaccines | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,702 | 2,145 | $460,626 | $135,290 |
| 2022 | 19 | 1,387 | 1,794 | $262,574 | $88,842 |
| 2021 | 17 | 1,346 | 1,788 | $256,865 | $84,400 |
| 2020 | 20 | 1,315 | 1,886 | $264,103 | $77,221 |
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 127 | 127 | $109,172 | $35,850 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 253 | 470 | $94,470 | $28,428 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 167 | 285 | $112,860 | $27,951 | 24.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 54 | 61 | $33,855 | $8,968 | 26.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 18 | $15,390 | $4,218 | 27.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 130 | 130 | $8,060 | $4,202 | 52.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 53 | 53 | $11,240 | $3,809 | 33.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 172 | 172 | $9,804 | $3,349 | 34.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 270 | 314 | $14,130 | $3,308 | 23.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 23 | 23 | $9,200 | $3,150 | 34.2% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 142 | 142 | $7,333 | $2,512 | 34.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 75 | 100 | $7,100 | $1,760 | 24.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 54 | 54 | $3,348 | $1,745 | 52.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 24 | 33 | $5,313 | $1,455 | 27.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 32 | $5,632 | $1,292 | 22.9% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 12 | 12 | $4,344 | $1,117 | 25.7% |
| G0102 | Prostate cancer screening; digital rectal examination | Office | 2023 | 72 | 72 | $5,112 | $1,021 | 20.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 31 | 33 | $3,465 | $882.64 | 25.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 14 | 14 | $798.00 | $272.58 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 254 | 489 | $98,289 | $29,710 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 130 | 222 | $64,602 | $21,318 | 33.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 48 | 51 | $19,941 | $7,499 | 37.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 25 | 25 | $9,500 | $6,939 | 73.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 66 | 67 | $9,380 | $4,586 | 48.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 156 | 156 | $7,488 | $3,064 | 40.9% |
About Dr. Gregory Kaczmarek, MD
Dr. Gregory Kaczmarek, MD is a Internal Medicine healthcare provider based in Skokie, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629032958.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Kaczmarek, MD has received a total of $22,496 in payments from pharmaceutical and medical device companies, with $2,948 received in 2024. These payments were reported across 1,338 transactions from 80 companies. The most common payment nature is "Food and Beverage" ($22,347).
As a Medicare-enrolled provider, Kaczmarek has provided services to 5,750 Medicare beneficiaries, totaling 7,613 services with total Medicare billing of $385,754. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Skokie, IL
- Active Since 04/13/2006
- Last Updated 05/12/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629032958
Products in Payments
- JARDIANCE (Drug) $719.02
- Saxenda (Drug) $674.55
- SYMBICORT (Drug) $654.46
- VRAYLAR (Drug) $647.36
- XIFAXAN (Drug) $631.07
- NURTEC ODT (Drug) $628.29
- Ozempic (Drug) $573.04
- Wegovy (Drug) $555.16
- XARELTO (Drug) $547.05
- UBRELVY (Drug) $544.57
- CHANTIX (Drug) $522.11
- FARXIGA (Drug) $521.64
- ELIQUIS (Drug) $519.02
- PREVNAR 20 (Biological) $513.96
- BREZTRI (Drug) $507.34
- SHINGRIX (Biological) $417.61
- Otezla (Drug) $417.31
- Aimovig (Biological) $395.53
- LINZESS (Drug) $330.66
- MOUNJARO (Drug) $271.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Skokie
Liana Billings, Md, Mmsc, MD, MMSC
Internal Medicine — Payments: $387,410
Gregory Mishkel, M.d, M.D
Internal Medicine — Payments: $61,716
Greg Denenberg, Md, MD
Internal Medicine — Payments: $25,547
Dr. Stephen Kashian, Md, MD
Internal Medicine — Payments: $23,403
Dr. Cliff Ireland, D.o, D.O
Internal Medicine — Payments: $22,598
Dr. Anuj Lal, Md, MD
Internal Medicine — Payments: $21,248